Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist — the first peptide of its kind to reach commercial availability. Research interest spans metabolic regulation, weight management studies, and cardiovascular outcomes.
Also known as: Mounjaro (brand), Zepbound (brand)
Technical information
Molecular weight
4813.45 g/mol
Half-life
~5 days
Sequence
Y(Aib)EGTFTSDYSI(Aib)LDKIAQKAFVQWLIAGGPSSGAPPPS
Common research doses
2.5-15 mg/week (research protocols)
Research areas
For research purposes only. PepAssure provides vendor information as a verification service and does not endorse or recommend any specific use. Consult qualified research protocols and institutional review boards.
Best Verified Vendors for Tirzepatide
Ranked by PVS score — independent verification, no paid placements.
USA · 99.4% reported purity · 62+ COAs
EU · 99.2% reported purity · 99+ COAs
USA · 99.2% reported purity · 73+ COAs
USA · 99.1% reported purity · 86+ COAs
International · 99.0% reported purity · 53+ COAs